يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Heterocyclic Compounds::Heterocyclic Compounds, Fused-Ring::Heterocyclic Compounds, 2-Ring::Quinoxalines::Brimonidine Tartrate [CHEMICALS AND DRUGS]"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Grauslund J] Department of Ophthalmology, Odense University Hospital, Odense, Denmark. Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. [Frydkjaer-Olsen U] Department of Ophthalmology, Odense University Hospital, Odense, Denmark. Department of Clinical Research, University of Southern Denmark, Odense, Denmark. [Peto T] Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Centre for Public Health, Institute of Clinical Sciences, Queen's University Belfast, Belfast, United Kingdom. [Fernández-Carneado J, Ponsati B] BCN Peptides, Barcelona, Spain. [Hernández C, Simó R] Grup de recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain., Hospital Universitari Vall d'Hebron

    المصدر: Scientia

  2. 2

    المساهمون: Institut Català de la Salut, [Grauslund J] Department of Ophthalmology, Odense University Hospital, Odense, Denmark. Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. [Frydkjaer-Olsen U] Department of Ophthalmology, Odense University Hospital, Odense, Denmark. Department of Clinical Research, University of Southern Denmark, Odense, Denmark. [Peto T] Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Centre for Public Health, Institute of Clinical Sciences, Queen's University Belfast, Belfast, United Kingdom. [Fernández-Carneado J, Ponsati B] BCN Peptides, Barcelona, Spain. [Hernández C, Simó R] Grup de recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain., Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Grauslund, J, Frydkjaer-Olsen, U, Peto, T, Fernández-Carneado, J, Ponsati, B, Hernández, C, Cunha-Vaz, J, Simó, R & EUROCONDOR 2019, ' Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR ', Investigative Ophthalmology & Visual Science, vol. 60, no. 6, pp. 2257-2262 . https://doi.org/10.1167/iovs.18-26487
    Grauslund, J, Frydkjaer-Olsen, U, Peto, T, Fernández-Carneado, J, Ponsati, B, Hernández, C, Cunha-Vaz, J & Simó, R 2019, ' Topical treatment with brimonidine and somatostatin causes retinal vascular dilation in patients with early diabetic retinopathy from the EUROCONDOR ', Investigative Opthalmology and Visual Science . https://doi.org/10.1167/iovs.18-26487
    Scientia

    مصطلحات موضوعية: Male, Vasodilatadors, Type 2 diabetes, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::/efectos de los fármacos [Otros calificadores], hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas peptídicas::hormonas hipotalámicas::hormonas inhibidoras de la liberación de hormonas hipofisarias::somatostatina [COMPUESTOS QUÍMICOS Y DROGAS], chemistry.chemical_compound, 0302 clinical medicine, Adrenergic alpha-2 Receptor Agonists, Prospective Studies, Other subheadings::/drug effects [Other subheadings], Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], Compostos heterocíclics, 0303 health sciences, General Medicine, Diabetic retinopathy, Middle Aged, 3. Good health, compuestos heterocíclicos::compuestos heterocíclicos con anillos de fusión::compuestos heterocíclicos de 2 anillos::quinoxalinas::tartrato de brimonidina [COMPUESTOS QUÍMICOS Y DROGAS], Neuroprotective Agents, Somatostatin, Brimonidine Tartrate, Female, medicine.drug, Adult, medicine.medical_specialty, Placebo, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Diabetes mellitus, Ophthalmology, Multicenter trial, medicine, Humans, Aged, 030304 developmental biology, Eye Diseases::Retinal Diseases::Diabetic Retinopathy [DISEASES], Diabetic Retinopathy, business.industry, Brimonidine, Retinal Vessels, Retinal, oftalmopatías::enfermedades de la retina::retinopatía diabética [ENFERMEDADES], Heterocyclic Compounds::Heterocyclic Compounds, Fused-Ring::Heterocyclic Compounds, 2-Ring::Quinoxalines::Brimonidine Tartrate [CHEMICALS AND DRUGS], medicine.disease, Retinopatia diabètica - Tractament, Somatostatina, Diabetes Mellitus, Type 2, chemistry, 030221 ophthalmology & optometry, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Hypothalamic Hormones::Pituitary Hormone Release Inhibiting Hormones::Somatostatin [CHEMICALS AND DRUGS], business

    وصف الملف: application/pdf